Rexulti, Advertising Profile, See Their Ad Spend!
Por um escritor misterioso
Descrição
New Drug Product: REXULTI - MPR
Life, Free Full-Text
Digital Ads Benchmark Report By Tinuiti, Q2 2023
The Madness of Pop Psychiatry - by Nick Jikomes, PhD
Digital Ads Benchmark Report By Tinuiti, Q2 2023
Otsuka, Lundbeck head into key FDA hearing with agency support
Agency 100 2023: MRM for Health
Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti
Kasia Rothenberg - Geriatric Psychiatry - The Cleveland Clinic
Otsuka, Lundbeck's sNDA for Rexulti received US FDA approval
Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer's Dementia
de
por adulto (o preço varia de acordo com o tamanho do grupo)
